ArticleAmerican health & drug benefits2019

Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia.

David Campbell et al.PubMed ↗Full text ↗

No numbers read from the abstract.